News

There’s a gap between what you want to do and what you do, advice columnist Eleanor Gordon-Smith writes. Thinking about how ...
If this all sounds too complicated, let’s go back to Occam’s Razor. The simplest explanation is usually the right one. And ...
In October 2021, the artist Serge Attukwei Clottey watched anxiously as a painting he had made just a few months earlier went ...
Q1 2025 Earnings Conference Call May 7, 2025 8:30 AM ETCompany ParticipantsAlex Giaimo - Head of Investor RelationsMatthew ...
From Germany labeling its second-largest party "extremist" to Sweden paying immigrants $35,000 to leave to nuclear tensions ...
The families of two Americans detained in China are urging the U.S. government to secure their loved-ones' release ...
Carrier Transicold has launched the second generation of its electric Vector eCool TRU, or trailer refrigeration unit. It comes with a new battery, a ...
Spain and Portugal faced a major power outage with unclear causes. Experts debate whether renewable energy transition, ...
Two years after receiving an investigational gene therapy as part of a clinical trial co-led by UCLA’s Dr. Donald Kohn, nine children born with a life-threatening immune disorder are living free of ...
D-Wave Quantum faces financial challenges, competition, and high valuation, with unclear profitability and speculative ...
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the expansion of its cell and gene therapy (CGT) portfolio with an enhanced digital PCR (dPCR) workflow that now includes solutions ...
Kytopen and Aldevron announce collaboration to expedite cell therapy manufacturing by combining their novel technologies. High transgene expression and improved safety profile of Aldveron's ...